Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2000
02/24/2000CA2340182A1 Tace inhibitors
02/24/2000CA2340180A1 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones
02/24/2000CA2340086A1 A method of transducing mammalian cells, and products related thereto
02/24/2000CA2340068A1 Calcilytic compounds
02/24/2000CA2340053A1 C3a receptor ligands
02/24/2000CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000CA2339047A1 Secreted proteins and polynucleotides encoding them
02/24/2000CA2338878A1 Integrin receptor antagonists
02/24/2000CA2335813A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
02/24/2000CA2277242A1 Process for pyrrolidinyl hydroxamic acid compounds
02/23/2000EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors
02/23/2000EP0980526A1 Inhibitors of nuclear protein/nuclear receptor interaction
02/23/2000EP0980432A1 Chimeric opg polypeptides
02/23/2000EP0980424A2 Enzymatic nucleic acids: synthesis, selection and use
02/23/2000EP0980385A1 Peptides and compounds that bind to the il-5 receptor
02/23/2000EP0980383A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens
02/23/2000EP0980382A1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring
02/23/2000EP0980374A1 Phosphodiesterase 4-inhibiting diazepinoindolones
02/23/2000EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders
02/23/2000EP0980362A1 Substituted heterocycles and their use in medicaments
02/23/2000EP0980258A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
02/23/2000EP0980248A1 Improvements in or relating to long-acting antimicrobials
02/23/2000EP0898579B1 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
02/23/2000EP0832063B1 Vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments
02/23/2000CN1245536A Novel calpaines, production and use thereof
02/23/2000CN1245496A 3-pyridyl enantiomers and their use as analgesics
02/23/2000CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity
02/23/2000CN1245431A Medical composition and use thereof for manufacture of topical barrir formulation, UV-radiation absorbing formulation, or antiviral, antifungal, or antiinflammatory formulation
02/23/2000CN1245070A Exterior-applied medicinal powder for treating menalgia and its preparing process
02/23/2000CN1049659C Corticotropin releasing factor antagonists
02/23/2000CN1049651C Metalloproteinase inhibitors
02/22/2000US6028222 Stable liquid paracetamol compositions, and method for preparing same
02/22/2000US6028169 Chemokine β-6 antagonists
02/22/2000US6028111 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
02/22/2000US6028110 Succinyl hydroxamic acid, N-formyl-N-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
02/22/2000US6028090 Adhesion receptor antagonists III
02/22/2000US6028072 For treating inflammation and inflammation related disorders
02/22/2000US6028060 Treatment of chronic inflammatory diseases with CM101/GBS toxin
02/22/2000US6027927 Human trk receptors and neurotrophic factor inhibitors
02/17/2000WO2000008202A2 3-methylidenyl-2-indolinone modulators of protein kinase
02/17/2000WO2000008177A2 Death associated kinase containing ankyrin repeats (dakar)
02/17/2000WO2000008158A2 Molecules designated ldcam
02/17/2000WO2000008141A2 Short oligonucleotides for the inhibition of vegf expression
02/17/2000WO2000008140A2 Antisense oligonucleotides for the inhibition of vegf expression
02/17/2000WO2000008139A1 Tumor necrosis factor-gamma
02/17/2000WO2000008024A1 Substituted imidazo[1,2a]azines as selective inhibotors of cox-2
02/17/2000WO2000008013A2 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
02/17/2000WO2000008007A2 Cyclopentabenzofuran derivatives and their use
02/17/2000WO2000007991A1 Amide derivatives useful as inhibitors of the production of cytokines
02/17/2000WO2000007980A1 Amide derivatives which are useful as cytokine inhibitors
02/17/2000WO2000007977A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments
02/17/2000WO2000007601A1 Ophtalmic solution with tetracycline for topical treatment of dry eye disease
02/17/2000WO2000007591A1 INDOLE sPLA2 INHIBITORS
02/17/2000WO2000007590A1 INDOLE sPLA2 INHIBITORS
02/17/2000WO2000007588A1 Pharmaceutical composition for injection based on paracetamol
02/17/2000WO2000007569A1 Compressed compositions comprising clarified xanthan gum
02/17/2000WO2000007568A1 Method for making coated gabapentine or pregabaline particles
02/17/2000WO2000007567A1 Medicinal aerosol formulations
02/17/2000WO2000007544A2 Vitronectin receptor antagonists
02/17/2000WO1999065942A8 Cyclic somatostatin analogs
02/17/2000WO1999056763A9 Use of neglected target tissue antigens in modulation of immune responses
02/17/2000WO1999054310A3 New substituted amides, their production and their use
02/17/2000DE19830105C1 Acridinderivate Acridine
02/17/2000CA2383623A1 3-methylidenyl-2-indolinone modulators of protein kinase
02/17/2000CA2339666A1 Vitronectin receptor antagonists
02/17/2000CA2339416A1 Short oligonucleotides for the inhibition of vegf expression
02/17/2000CA2339340A1 Antisense oligonucleotides for the inhibition of vegf expression
02/17/2000CA2339187A1 Substituted imidazo¬1,2a|azines as selective inhibitors of cox-2
02/17/2000CA2339086A1 Dna replication- and repair-associated proteins
02/17/2000CA2338855A1 Indole spla2 inhibitors
02/17/2000CA2338727A1 Indole spla2 inhibitors
02/17/2000CA2338385A1 Human receptor-associated proteins
02/17/2000CA2338173A1 Method for making coated gabapentine or pregabaline particles
02/17/2000CA2338121A1 Amide derivatives useful as inhibitors of the production of cytokines
02/17/2000CA2305680A1 Death associated kinase containing ankyrin repeats (dakar)
02/16/2000EP0979869A1 Short oligonucleotides for the inhibition of VEGF expression
02/16/2000EP0979817A1 Leukotriene a 4? hydrolaze inhibitors
02/16/2000EP0979282A1 Rat st38.2 chemokine
02/16/2000EP0979276A1 Complement receptor type 1 (cr1)-like sequences
02/16/2000EP0979230A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
02/16/2000EP0979228A1 Novel cannabinoid receptor agonists
02/16/2000EP0979090A1 Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine
02/16/2000EP0979087A1 Analgesic combination
02/16/2000EP0979079A1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
02/16/2000EP0979078A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents
02/16/2000EP0979077A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
02/16/2000CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use
02/16/2000CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase
02/16/2000CN1244526A Effective synthetic method for furau sulfonic acid amide compound for synthesizing new IL-1 inhibitor
02/16/2000CN1244422A Pain relieving ointment and its preparation
02/16/2000CN1244414A Immune rheumatism capsule
02/16/2000CN1049431C Morpholine derivative and its use and medicinal prepration containing said derivatives
02/16/2000CN1049333C Process for producing fine particulate materials
02/15/2000US6025494 Tetracyclic derivatives, process of preparation and use
02/15/2000US6025376 Chiral methylphenyloxazolidinones
02/15/2000US6025361 Effective pde iv inhibitors, asthma
02/15/2000US6025354 Exhibit phosphodiesterase iv inhibition and can be used to treat asthmatic disorders.
02/15/2000US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
02/15/2000US6025166 Human trk receptors and neurotrophic factor inhibitors
02/15/2000US6025147 Inhibitors of interleukin-1 β converting enzyme
1 ... 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 ... 1272